Vadhan-Raj, S., Fayad, L. E., Fanale, M. A., Pro, B., Rodriguez, A., Hagemeister, F. B., . . . Romaguera, J. E. (2012). A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Oxford University Press.
Chicago Stili AlıntıVadhan-Raj, S., et al. A Randomized Trial of a Single-dose Rasburicase Versus Five-daily Doses in Patients At Risk for Tumor Lysis Syndrome. Oxford University Press, 2012.
MLA AlıntıVadhan-Raj, S., et al. A Randomized Trial of a Single-dose Rasburicase Versus Five-daily Doses in Patients At Risk for Tumor Lysis Syndrome. Oxford University Press, 2012.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..